U.S. Banks Stock News

Denali Therapeutics (NasdaqGS:DNLI) received FDA approval for AVLAYAH, its first commercial drug for pediatric Hunter syndrome. The company reported a strong early launch for AVLAYAH, highlighting initial commercial traction for its brain penetrant platform. This milestone marks Denali's transition from a development focused biotech to a commercial stage company. The approval provides an initial test of Denali's approach to delivering therapies across the blood brain barrier for neurological...

Datadog (NasdaqGS:DDOG) took part in Dust's US$40 million Series B funding round to help scale Dust's multiplayer AI platform. The move links Datadog more closely to AI-native collaboration tools that aim to connect multiple users and AI agents inside enterprise workflows. This development has drawn attention because it touches Datadog's role in observability, AI-driven operations, and collaboration infrastructure. Datadog is best known for its cloud monitoring and observability tools, but...

Robert Half (NYSE:RHI) reports that small business hiring optimism is holding up, according to a new company survey. Respondents indicate growing use of external staffing partners as AI generated job applications make screening candidates more complex. The survey points to a shift in how smaller firms source and assess talent, with staffing specialists playing a larger role. For investors tracking NYSE:RHI, this survey sits within the company’s core business of professional staffing and...

LiveRamp Holdings (RAMP) has just posted its FY 2026 numbers, with fourth quarter revenue of US$206.1 million and basic EPS of US$1.12, alongside net income from ongoing operations of US$69.7 million and an additional US$1.2 million from discontinued operations. Over recent periods, revenue has moved from US$188.7 million in FY 2025 Q4 to US$206.1 million in FY 2026 Q4, while quarterly basic EPS shifted from a loss of US$0.10 in FY 2025 Q4 to a profit of US$1.12 in FY 2026 Q4. This sets up a...

Par Pacific Holdings, Inc. recently completed a US$500 million private placement of 7.375% senior unsecured notes due June 1, 2034, alongside amendments to expand and extend its asset-based revolving credit facility, while also reporting first-quarter 2026 results with higher sales and a swing to net income versus the prior year. At the same time, the company has been active in reshaping its capital structure through debt refinancing and share repurchases, choices that interact directly with...

In the first quarter of 2026, Klarna Group plc reported revenue of US$1,012 million versus US$701 million a year earlier, with net loss narrowing to US$5 million and loss per share improving to US$0.01, while guiding second-quarter revenue to US$960–US$1,000 million and reaffirming positive full-year expectations. A series of partnerships, including bringing Klarna’s flexible payment options into Google’s Gemini app and Search via Google Pay in the U.S. and expanding to Minor Hotels’...

Pictet Asset Management has disclosed beneficial ownership of 4.51% of Dynatrace (NYSE:DT). The asset manager is engaging directly with Dynatrace on governance, strategy, and sustainability topics. Pictet states it is not seeking control of the company and plans ongoing dialogue with management and the board. Dynatrace focuses on software intelligence, helping enterprises monitor and manage complex cloud environments. For readers following NYSE:DT, the new 4.51% position from Pictet adds...

Mistras Group, Inc.'s ( NYSE:MG ) earnings announcement last week was disappointing for investors, despite the decent...

Readers hoping to buy Bank of the James Financial Group, Inc. ( NASDAQ:BOTJ ) for its dividend will need to make their...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Quad/Graphics, Inc. ( NYSE:QUAD ) stock is about to trade ex-dividend in 2 days. Typically, the ex-dividend date is one...

Investors were disappointed with the weak earnings posted by Onto Innovation Inc. ( NYSE:ONTO ). However, our analysis...

Align Technology, Inc.'s ( NASDAQ:ALGN ) recent earnings report didn't offer any surprises, with the shares unchanged...

The United States market has remained flat over the last week, yet it has experienced a 24% rise over the past 12 months with earnings forecast to grow by 17% annually. In such an environment, identifying stocks that may be priced below their estimated value can offer potential opportunities for investors looking to capitalize on anticipated growth.

In the last week, the United States market has stayed flat, yet it is up 24% over the past year, with earnings expected to grow by 17% per annum over the next few years. In this environment, stocks with strong growth potential and high insider ownership can be particularly appealing as they may indicate confidence from those most familiar with the company's prospects.

Over the last 7 days, the market has remained flat, but over the past 12 months, it has risen by 24%, with earnings expected to grow by 17% per annum in the coming years. Investing in penny stocks can still open doors to growth opportunities, typically in smaller or newer companies. While once a buzzword and now more of a niche term, penny stocks represent an underappreciated chance for growth at lower price points when backed by strong financial health and solid fundamentals.

The United States market has experienced a flat performance over the last week, yet it has seen a significant 24% increase over the past year with earnings projected to grow by 17% annually. In this dynamic environment, identifying stocks with strong fundamentals and growth potential can be key to uncovering undiscovered gems that may offer opportunities for investors.

The United States market remained flat over the last week but has shown a robust 24% increase over the past year, with earnings expected to grow by 17% annually. In this context, identifying strong dividend stocks can be an effective strategy for investors seeking steady income and potential capital appreciation amidst these dynamic market conditions.

United Fire Group, Inc. reported past first-quarter 2026 results with revenue of US$369.44 million, net income of US$30.05 million, and diluted EPS from continuing operations of US$1.15, all higher than the same period a year earlier. The combination of higher revenue and a sizable increase in net income points to improved underwriting and expense performance that may influence how investors assess the insurer’s operating trajectory. We’ll now consider how this stronger first-quarter...

Earlier this month, Littelfuse, Inc. reported first-quarter 2026 results showing sales of US$656.97 million and net income of US$75.15 million, issued second-quarter net sales guidance of US$690 million to US$710 million, reaffirmed a US$0.75 per-share dividend for June 4, 2026, and outlined ongoing acquisition plans alongside its upcoming Investor Day. For investors, the combination of stronger quarterly earnings, acquisition intentions, and clearer communication of long-term goals offers a...

STAAR Surgical reported past first-quarter 2026 results with net sales of US$93.52 million, a very large increase from US$42.59 million a year earlier, and moved from a net loss to net income of US$5.21 million. The quarter underscored how resurgent demand in China for EVO+ lenses, combined with expanding U.S. indications and tighter cost control, has transformed the company’s profitability profile. We’ll now examine how this sharp earnings rebound, powered by EVO+ lens demand in China,...

Recent performance and why GCI Liberty is on investors’ radar GCI Liberty (GLIB.A) has drawn fresh attention after a period of weaker share performance, with the stock down about 32% over the past month and 35% over the past 3 months. See our latest analysis for GCI Liberty. With the share price at US$25.59 and short term share price returns of 10.9% over the past week and 32.4% over the past month, recent weakness has added to a year to date share price decline of 28.6%. This suggests...

Perimeter Solutions (PRM) has drawn fresh attention after first quarter 2026 results showed sales of US$125.07 million and net income of US$72.94 million, along with a renewed emphasis on acquisitions and disciplined capital deployment. See our latest analysis for Perimeter Solutions. The earnings and acquisition comments have landed after a strong run in the stock, with a 30 day share price return of 19.53% and a 1 year total shareholder return of 181.13%, suggesting that momentum has been...

Nurix Therapeutics (NRIX) is back in focus after reporting new preclinical and Phase 1 data for its BTK degrader NX-5948, and after securing an oral presentation slot at the European Hematology Association Congress. See our latest analysis for Nurix Therapeutics. Despite the recent NX-5948 data and the upcoming European Hematology Association presentation, Nurix Therapeutics’ share price has eased over the past month, with a 30 day share price return of 9.45% down, even as the 1 year total...